サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：慢性血液透析カテーテルの世界市場-2023年～2030年
市場調査レポート
商品コード
1374768

慢性血液透析カテーテルの世界市場-2023年～2030年

Global Chronic Hemodialysis Catheter Market - 2023-2030

出版日
ページ情報
英文 190 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
慢性血液透析カテーテルの世界市場-2023年～2030年
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界の慢性血液透析カテーテル市場は、さまざまな要因がそのダイナミクスに影響を与えながら、長年にわたって大きな成長と変貌を遂げてきました。HDC（血液透析カテーテル）は腎代替療法の重要な要素です。これらのカテーテルは、動静脈瘻やグラフトのような、より恒久的なバスキュラーアクセスを設置する前の一時的な解決策としか考えられていないです。

特に新興経済諸国における政府投資と研究開発は、今後も先進技術の利用を促進し、世界の慢性血液透析カテーテル市場を押し上げると思われます。それぞれの革新的なデバイスには、より良い治療のためのシリコーンやポリウレタンなどの新素材の使用が含まれます。

市場力学：促進要因

主要プレーヤー別血液透析カテーテルの買収の増加

新興経済諸国は、高い所得水準、投資、インフラ整備に牽引され、ヘルスケア分野の改善において急速な成長を遂げています。慢性血液透析用カテーテルは、その良好な研究成果により、いくつかの国で大きな需要が生じています。主要企業による様々な買収や製品の発売は、市場の成長を促進する重要な要因です。

2023年6月8日、AngioDynamics, Inc.の透析カテーテルデバイスのポートフォリオと生検管シーラント技術BioSentryが、ヘルスケア技術の製造・販売で国際的に知られるMerit Medical Systems, Inc.に現金総額1億米ドルで買収されました。

インターナショナル・ジャーナル・オブ・クリニカル・プラクティス2022によると、頤和山病院付属万南医科大学が実施した研究の結果、トンネル・カフド・カテーテル（TCC）の平均生存期間は2年以上であることが示されました。年齢、性別、原疾患に関係なく、TCCは、血管状態が悪い、あるいは生存期間が短い維持血液透析（MHD）患者、あるいは内瘻の成長を待つ間のつなぎとして有効な選択肢であることがわかっています。

さらに、透析管理のための新しい技術や機器の利用が増加しています。人々の意識の高まりと革新的なデバイス開発のための研究の増加は、慢性血液透析カテーテル市場の成長を促進する主な要因です。

市場力学：抑制要因

カテーテルに伴う合併症

臨床成績の悪化は、慢性的にトンネル状になった血液透析カテーテルが原因のひとつである可能性があります。血液透析カテーテルの主な問題は、感染、中心静脈の狭窄や閉塞、血栓症やフィブリンシースによる機能低下です。血栓症やフィブリン鞘は血流を障害し、特に動脈管腔からの流入を減少させるため、不十分な血液透析の原因となります。

短期的な困難は、医療従事者の経験の浅さ、アクセス部位、留置手技、患者の疾患の重症度、合併症など、手技そのものに起因することがあります。HDCの長期的影響としては、機械的機能障害、血栓症、中心静脈狭窄、カテーテル関連血流感染（CRBSI）などがあります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 主要プレーヤー間での血液透析カテーテル買収の増加
      • 技術的進歩と開発の高まり
    • 抑制要因
      • カテーテルに伴う合併症
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 価格分析
  • SWOT分析
  • 特許分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 タイプ別

  • カフ付きトンネルカテーテル
  • 非カフ式トンネルカテーテル
  • 非トンネル型カテーテル

第8章 先端デザイン別

  • ステップチップ
  • スプリットチップ
  • 対称チップ
  • セルフセンタリング・チップ
  • Yチップ

第9章 コーティング

  • ヘパリン被覆カテーテル
  • ポリウレタン・コーティング
  • 抗生物質コーティング
  • その他

第10章 エンドユーザー別

  • 病院
  • 専門クリニック
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Teleflex Incorporated
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Medtronic
  • BD
  • AngioDynamics
  • Medical Components, Inc.
  • Merit Medical Systems
  • Fresenius Medical Care AG & Co. KGaA
  • Haolang Technology（Foshan）Limited Co., Ltd.
  • SCW Medicath Ltd
  • Vygon

第14章 付録

目次
Product Code: MD7161

Overview

The global chronic hemodialysis catheter market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. HDCs (hemodialysis catheters) are a crucial component of kidney replacement therapy. These catheters are only seen as a temporary solution before installing more permanent vascular access, like arteriovenous fistulas or grafts.

Government investments and research, particularly in developing economies, will continue to drive utilization of advanced technologies and boost the global chronic hemodialysis catheter market. The respective innovative devices includes the use of novel materials such as silicone or polyurethane for better treatment.

Market Dynamics: Drivers

Growing acquisitions of hemodialysis catheters among key players

Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high income levels, investments and infrastructure development. Several countries have experienced substantial demand for chronic hemodialysis catheter owing to its positive outcomes in research. Various acquisitions and product launches among key players will be a crucial factor driving the growth of the market.

On June 8, 2023, a portfolio of dialysis catheter devices and the Biopsy Tract Sealant Technology, BioSentry from AngioDynamics, Inc. have been acquired by Merit Medical Systems, Inc., an internationally recognized manufacturer and distributor of healthcare technology, for a total cash valuation of $100 million.

According to International Journal of Clinical Practices 2022, the results of the study conducted by Wannan Medical College associated with Yijishan Hospital show that the average Tunneled Cuffed Catheters (TCC) survive longer than two years. Regardless of age, sex, or primary condition, we discovered that TCC is an effective option for patients with Maintenance Hemodialysis (MHD) with poor vascular status or short survival time, or as a bridge while waiting for an internal fistula to grow.

Furthermore, the rising utilization of novel technologies or devices for the management of dialysis. Rising awareness among people and increasing research for innovative device development will be a major factor driving the growth of the chronic hemodialysis catheters market.

Market Dynamics: Restraints

Complications associated with the catheter

Poor clinical results may be caused in part by hemodialysis catheters that have been chronically tunneled. The main issues with hemodialysis catheters involve infection, central vein stenosis and blockage, and poor function brought on by thrombosis and fibrin sheath. Inadequate hemodialysis can result from thrombosis or fibrin sheath because they impair blood flow, especially by reducing inflow via the arterial lumen.

Short-term difficulties can be caused by the procedure itself, such as the inexperience of the provider, the site of access, the placement technique, the severity of the patient's disease, and concomitant conditions. The long-term effects of HDC include mechanical dysfunction, thrombosis, central venous stenosis, and catheter-related bloodstream infection (CRBSI).

Segment Analysis

The global chronic hemodialysis catheter market is segmented based on type, tip design, coating, end user and region.

Cuffed Tunneled Catheter segment holds approximately 41% of market share

Prior to the development or maturity of a long-term dialysis availability, such as an arteriovenous fistula (AVF) and arteriovenous grafty (AVG), tunneled catheters are utilized to provide vascular access. They are also utilized by patients who have used every available entry point for long-term access to dialysis. To reduce catheter disintegration, vascular harm, and catheter-related problems, tunneled catheters are composed of flexible materials like silicone or polyurethane-polycarbonate copolymer.

In general, polyurethane-polycarbonate copolymers are biocompatible. Tunneled cuffed catheters had been subsequently created, and the cuff's goal is to build a fibrous tissue that may act as a barrier preventing infection. Furthermore, by limiting displacement, the cuff and the related fibrous tissue may also offer a more stable access.

According to Indian Journal of Radiology and Imaging article 2023, tunneled lines are linked to greater long-term results, but the insertion procedure is more difficult and intrusive. In patients expected to need HD for longer than 2 to 3 weeks, cuffed TDCs are thus preferred over non-tunneled catheters, unless the situation is urgent and speedy access is required. The majority of qualified applicants for a TDC have a history of documented chronic kidney disease (CKD).

Geographical Penetration

North America accounted for around 33% of market share in 2022

Due to the rising need for chronic hemodialysis catheter in healthcare, manufacturers in North America have chances of increasing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for chronic hemodialysis catheter.

Increasing expenditure on healthcare and rising research studies, advancement of technologies and different type of devices for management, and increase in pharmaceutical or medical device business establishment across the region are also contributing to the growth of chronic hemodialysis catheter market share of this region. The market in this area is growing as people become more aware of various novel innovative products such as tunneled catheters. The aforementioned elements further attest to North America's hegemonic position in the world.

North America continues to be a key player in the global chronic hemodialysis catheter market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for chronic hemodialysis catheter in the U.S. United States have been proactive in executing several initiatives or researches, stimulating chronic hemodialysis catheter demand.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global chronic hemodialysis catheter market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all throughout the world were impacted by the pandemic's broad lockdowns and limitations that started in early 2020.

Major medical device industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for chronic hemodialysis catheter. Now several research studies have been initiated and companies have again started trial for their products safety and efficacy. Overall, the impact of the pandemic on the global chronic hemodialysis catheter market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for antimicrobial coated, self-cenetered catheter and other programs for management of renal kidney disease.

Key Developments

  • On August 21, 2023, the Arrow ErgoPack Comprehensive Kits with Hemodialysis plus Large Bore Catheters have been made available in the United States, according to Teleflex Incorporated, a top global manufacturer of medical technologies. The goal of this upgrade is to give clinicians more alternatives and streamline their insertion routine. With a selection of French diameters, lumens, and lengths, this extended kit configuration gives clinicians the option of using either Arrowg + ard Blue Hemodialysis and Large Bore lines.
  • On April 14, 2021, the U.S. Food and Drug Administration (FDA) granted 510(k) approval to BD (Becton, Dickinson and business), a preeminent worldwide medical technology business, for the Pristine a long-term Hemodialysis Catheter, a brand-new hemodialysis catheter with a distinctive symmetric Y-Tip side-hole free distal lumen design.

Competitive Landscape

The major global players in the market include: Teleflex Incorporated, Medtronic, BD, AngioDynamics, Medical Components, Inc., Merit Medical Systems, Fresenius Medical Care AG & Co. KGaA, Haolang Technology (Foshan) Limited Co., Ltd., SCW Medicath Ltd and Vygon.

Why Purchase the Report?

  • To visualize the global chronic hemodialysis catheter market segmentation based on type, tip design, coating, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of chronic hemodialysis catheter market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global chronic hemodialysis catheter market report would provide approximately 69 tables, 69 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Tip Design
  • 3.3. Snippet by Coating
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing acquisitions of hemodialysis catheters among key players
      • 4.1.1.2. Rising technological advancements and developments
    • 4.1.2. Restraints
      • 4.1.2.1. Complications associated with the catheter
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Pricing Analysis
  • 5.6. SWOT Analysis
  • 5.7. Patent Analysis
  • 5.8. Russia-Ukraine War Impact Analysis
  • 5.9. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Cuffed Tunneled Catheter*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Non-cuffed Tunneled Catheter
  • 7.4. Non-tunneled Catheter

8. By Tip Design

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 8.1.2. Market Attractiveness Index, By Tip Design
  • 8.2. Step-Tip*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Split-Tip
  • 8.4. Symmetrical-Tip
  • 8.5. Self-centering Tip
  • 8.6. Y-Tip

9. By Coating

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 9.1.2. Market Attractiveness Index, By Coating
  • 9.2. Heparin-coated Catheters *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Polyurethane Coating
  • 9.4. Antibiotic Coating
  • 9.5. Other

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Specialty Clinics
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Teleflex Incorporated*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Medtronic
  • 13.3. BD
  • 13.4. AngioDynamics
  • 13.5. Medical Components, Inc.
  • 13.6. Merit Medical Systems
  • 13.7. Fresenius Medical Care AG & Co. KGaA
  • 13.8. Haolang Technology (Foshan) Limited Co., Ltd.
  • 13.9. SCW Medicath Ltd
  • 13.10. Vygon

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us